1. Home
  2. Labeler Index
  3. Bryant Ranch Prepack
  4. 72162-1744
  5. Product Images: Felodipine

Product Images Felodipine

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. image description - 1 formula
  2. Label - lbl721621744
  3. table 1 - table 1
  4. table 2 - table 2

Product Label Images

The following 4 images provide visual information about the product associated with Felodipine NDC 72162-1744 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - 1 formula

image description - 1 formula

Label - lbl721621744

Label - lbl721621744

table 1 - table 1

table 1 - table 1

Mean reductions in blood pressure were measured in two different studies. In Study 1, at doses of 25mg, 5mg, and 10mg, the mean reductions in systolic blood pressure were 947mmHg, 950mmHg, and 181mmHg, respectively. The mean reductions in diastolic blood pressure were 271mmHg, 245mmHg, and 100mmHg, respectively. Study 2, which lasted for 4 weeks, included a dose of 20mg, resulting in mean reductions of 537mmHg for systolic blood pressure and 455mmHg for diastolic blood pressure. It is worth noting that the number of patients available for peak and trough measurements varied between the studies.*

table 2 - table 2

table 2 - table 2

Percent of Patients with Adverse Events in Controlled Trials of Felodipine Extended-Release Tablets: - Body System: - Placebo: Peripheral Edema (33%), Asthenia (33%), Warm Sensation (0%), Palpitation (24%), Nausea (15%), Dyspepsia (12%), Constipation (9%), Headache (102%), Dizziness (27%), Paresthesia (15%), Upper Respiratory Infection (1.8%), Cough (0%), Rhinorthea (0%), Sneezing (0%), Rash (9%), Flushing (9%) - 25mg: Peripheral Edema (2%), Asthenia (39%), Warm Sensation (0%), Palpitation (4%), Nausea (12%), Dyspepsia (39%), Constipation (12%), Headache (106%), Dizziness (27%), Paresthesia (16%), Upper Respiratory Infection (39%), Cough (8%), Rhinorthea (16%), Sneezing (16%), Rash (2%), Flushing (39%) - 5mg: Peripheral Edema (88%), Asthenia (33000), Warm Sensation (09%), Palpitation (14%), Nausea (17%), Dyspepsia (07%), Constipation (03%), Headache (11%), Dizziness (36%), Paresthesia (12000), Upper Respiratory Infection (19000), Cough (12000), Rhinorthea (02%), Sneezing (0%), Rash (02%), Flushing (53%) - 10mg: Peripheral Edema (174%), Asthenia (22%), Warm Sensation (15%), Palpitation (25%), Nausea (1%), Dyspepsia (5%), Constipation (15%), Headache (147%), Dizziness (37%), Paresthesia (12002), Upper Respiratory Infection (07%), Cough (17%), Rhinorthea (02%), Sneezing (0%), Rash (02%), Flushing (69%) Note: Percentages shown in parentheses indicate the incidence of discontinuations. Please note that patients in titration studies may have been exposed to more than one dose level of felodipine extended-release tablets.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.